Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate

Transplant Proc. 1988 Jun;20(3 Suppl 3):470-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Bone Marrow Transplantation*
  • Chronic Disease
  • Cyclosporins / adverse effects
  • Cyclosporins / therapeutic use*
  • Graft Survival
  • Graft vs Host Disease / prevention & control*
  • HLA Antigens / analysis
  • Humans
  • Methotrexate / therapeutic use*
  • Mouth Diseases / complications
  • Opportunistic Infections / complications
  • Sepsis / complications

Substances

  • Cyclosporins
  • HLA Antigens
  • Methotrexate